embecta to Participate in Investor Events

PARSIPPANY, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:

GlobeNewsWire • Jun 1, 2026

EMBC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Embecta Corp.

NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Embecta Corp. (“Embecta” or the “Company”) (NASDAQ:EMBC) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices.

GlobeNewsWire • May 29, 2026

Bragar Eagel & Squire, P.C. is Investigating Embecta Corp. on Behalf of Embecta Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Embecta (EMBC) To Contact Him Directly To Discuss Their Options

GlobeNewsWire • May 28, 2026

EMBC SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Embecta Corp. (“Embecta” or the “Company”) (NASDAQ:EMBC) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On May 5, 2026, the Company reported second quarter 2026 earnings, which announced results below analyst expec.

Business Wire • May 22, 2026

Levi & Korsinsky Investigating Whether Embecta Corp. (EMBC) Misled Investors - Securities Law Violations Possible

New York, New York--(Newsfile Corp. - May 21, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Embecta Corp. ("Embecta Corp.") (NASDAQ: EMBC) concerning potential violations of the federal securities laws. On November 25, 2025, CFO Jacob P.

Newsfile Corp • May 22, 2026

Embecta Corp. (EMBC) Securities Fraud Investigation - Levi & Korsinsky

Embecta's Q2 FY2026 revenue and EPS fell short of both company guidance and Wall Street consensus -- shares dropped more than 25% in a single session. NEW YORK, May 20, 2026 /PRNewswire/ -- Investors who held Embecta Corp. (NASDAQ: EMBC) shares lost more than 25% of their value when the stock collapsed after Q2 FY2026 earnings missed on both the top and bottom lines.

PRNewsWire • May 20, 2026

Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification

Embecta NASDAQ: EMBC President and CEO Devdatt Kurdikar said the company's recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and inventory-related factors, while emphasizing that the diabetes device maker is continuing a broader diversification strategy intended to make the business less dependent on its core insulin injection franchise.

MarketBeat • May 16, 2026

embecta Completes Acquisition of Owen Mumford Holdings Limited

PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has completed its previously announced transaction to acquire Owen Mumford Holdings Limited (“Owen Mumford”), a privately held, UK-based innovator and manufacturer of medical devices and drug delivery technologies.

GlobeNewsWire • May 15, 2026

Levi & Korsinsky Announces Investigation of Securities Claims Against Embecta Corp. (EMBC)

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (NASDAQ: EMBC) stock dropped more than 25% after the company reported Q2 FY2026 earnings release, which reported results below analyst expectations and included a reduction to full-year 2026 guidance. Shareholders who lost money on their Embecta investment are encouraged to submit their information here.

GlobeNewsWire • May 14, 2026

EMBC Investor Alert: Levi & Korsinsky Investigates Embecta Corp. (EMBC) for Potential Securities Fraud

Embecta guided investors toward a $1.071-$1.093 billion revenue outlook for FY2026 while internal indicators reportedly already signaled the need for a cut -- shares later fell more than 25%. NEW YORK, May 13, 2026 /PRNewswire/ -- Shareholders who purchased Embecta Corp. (NASDAQ: EMBC) stock lost more than 25% of their investment value after the company slashed its full-year FY2026 financial outlook, reversing guidance it had publicly reaffirmed just months earlier.

PRNewsWire • May 13, 2026